Bajetta E - Search Results

1

Treatment of cancer-related anemia with epoetin alfa: a review.

Ferrario E, Ferrari L, Bidoli P, De Candis D, Del Vecchio M, De Dosso S, Buzzoni R, Bajetta E. Ferrario E, et al. Among authors: bajetta e. Cancer Treat Rev. 2004 Oct;30(6):563-75. doi: 10.1016/j.ctrv.2004.04.005. Cancer Treat Rev. 2004. PMID: 15325036 Review.

2

Formestane as treatment of advanced breast cancer in elderly women.

Zilembo N, Buzzoni R, Celio L, Noberasco C, Ferrari L, Laffranchi A, Vicario G, Dolci S, Bajetta E. Zilembo N, et al. Among authors: bajetta e. Tumori. 1994 Dec 31;80(6):433-7. doi: 10.1177/030089169408000605. Tumori. 1994. PMID: 7900232 Clinical Trial.

3

Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer.

Ferrari L, Zilembo N, Bajetta E, Buzzoni R, Noberasco C, Martinetti A, Celio L, Galante E, Orefice S, Cerrotta AM. Ferrari L, et al. Among authors: bajetta e. Breast Cancer Res Treat. 1994;30(2):127-32. doi: 10.1007/BF00666055. Breast Cancer Res Treat. 1994. PMID: 7949210 Clinical Trial.

4

Hormone therapy in advanced breast carcinoma: present and future trends.

Bajetta E, Zilembo N, Di Leo A, Buzzoni R, Zampino MG, Biganzoli L, Noberasco C. Bajetta E, et al. Cancer Treat Rev. 1994 Jul;20(3):241-58. doi: 10.1016/0305-7372(94)90002-7. Cancer Treat Rev. 1994. PMID: 8020005 Review. No abstract available.

5

Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy.

Bajetta E, Zilembo N, Buzzoni R, Noberasco C, Celio L, Bichisao E. Bajetta E, et al. Cancer Treat Rev. 1993 Apr;19 Suppl B:31-6. doi: 10.1016/0305-7372(93)90005-c. Cancer Treat Rev. 1993. PMID: 8481932

6

A dose-finding study of lanreotide (a somatostatin analog) in patients with colorectal carcinoma.

Di Leo A, Bajetta E, Ferrari L, Biganzoli L, Mariani L, Carnaghi C, Camerini E, Buzzoni R, Ruiz JM. Di Leo A, et al. Among authors: bajetta e. Cancer. 1996 Jul 1;78(1):35-42. doi: 10.1002/(SICI)1097-0142(19960701)78:1<35::AID-CNCR7>3.0.CO;2-G. Cancer. 1996. PMID: 8646723

7

Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial.

Bajetta E, Chiara Stani S, De Candis D, Bidoli P, Mariani L, Zilembo N, Pozzi P, Procopio G. Bajetta E, et al. Cancer. 2000 Aug 15;89(4):763-8. doi: 10.1002/1097-0142(20000815)89:4<763::aid-cncr7>3.0.co;2-f. Cancer. 2000. PMID: 10951338 Clinical Trial.

8

Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors.

Bajetta E, Zilembo N, Bichisao E, Martinetti A, Buzzoni R, Pozzi P, Bidoli P, Ferrari L, Celio L. Bajetta E, et al. Ann Oncol. 2000 Aug;11(8):1017-22. doi: 10.1023/a:1008388823113. Ann Oncol. 2000. PMID: 11038039 Free article.

9

Capecitabine: indications and future perspectives in the treatment of metastatic colorectal and breast cancer.

Cassata A, Procoplo G, Alù M, Ferrari L, Ferrario E, Beretta E, Longarini R, Busto G, De Candis D, Bajetta E. Cassata A, et al. Among authors: bajetta e. Tumori. 2001 Nov-Dec;87(6):364-71. doi: 10.1177/030089160108700602. Tumori. 2001. PMID: 11989587 Review.

10

Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IV non-small-cell lung cancer.

Bajetta E, Stani SC, De Candis D, Zaffaroni N, Zilembo N, Cortinovis D, Aglione S, Mariani L, Formisano B, Bidoli P. Bajetta E, et al. Ann Oncol. 2003 Feb;14(2):242-7. doi: 10.1093/annonc/mdg060. Ann Oncol. 2003. PMID: 12562651 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters